Lyell Immunopharma, Inc. - COM (LYEL)

Historical Portfolio Holders from Q2 2021 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
133M
Holdings value Q2 2024
$194M
Value change Q2 2024
-$1.31M
Grand Portfolio weight change Q2 2024
0%
Number of holders
113
Number of buys Q2 2024
47
Number of sells Q2 2024
-65
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 57.6K $79K +$34.6K $1.37 1
2024 Q2 133M $194M -$1.31M $1.45 113
2024 Q1 133M $297M +$3.77M $2.23 122
2023 Q4 131M $255M +$1.52M $1.94 115
2023 Q3 122M $180M +$238K $1.47 101
2023 Q2 122M $389M +$15.2M $3.18 97
2023 Q1 118M $278M +$605K $2.36 96
2022 Q4 117M $405M +$13.8M $3.47 92
2022 Q3 112M $823M +$50.7M $7.33 86
2022 Q2 106M $688M +$42.2M $6.52 72
2022 Q1 99.5M $502M +$55.2M $5.05 78
2021 Q4 85.5M $662M -$22.1M $7.74 76
2021 Q3 82.5M $1.22B +$39.8M $14.80 61
2021 Q2 79.7M $1.29B +$1.29B $16.24 52